Skip to main content

Advertisement

Log in

Use of Methylene Blue for Detection of Specialized Intestinal Metaplasia in GERD Patients Presenting for Screening Upper Endoscopy

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

The ability of randomly obtained biopsy specimens to identify intestinal metaplasia in the distal esophagus is low. Use of vital staining has been suggested, as stains are taken up by areas histologically identified as specialized intestinal metaplasia (SIM). This study evaluated the role of methylene blue (MB) staining for identification of SIM in GERD patients undergoing a screening endoscopy. Chromoendoscopy of the distal esophagus using 1% MB was performed on 52 GERD patients presenting for their first endoscopy. Biopsies were obtained from areas that were stained darkly, stained lightly, unstained, or macroscopically abnormal. In patients with no MB staining, four-quadrant biopsy of the distal esophagus was performed. Twenty-seven patients (52%) showed staining with MB, while 25 patients did not. Two hundred sixty-six biopsies were obtained. SIM was detected in 11 (21%) subjects (SIM+) but not in the remaining 41 (SIM−). One hundred sixty-five biopsies were unstained (25 SIM+, 140 SIM−) and 101 were stained (12 SIM+, 89 SIM−). The per-biopsy sensitivity and specificity of MB for detection of SIM were 32.4 and 85%, while the per-patient sensitivity and specificity were 63.3 and 51.2%. MB staining for detection of SIM in GERD patients without a macroscopic appearance suggestive of a columnar-lined esophagus is a poor screening tool for SIM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Sampliner RE: Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 93:1028–1032, 1998

    Article  CAS  PubMed  Google Scholar 

  • Falk GW: Endoscopic surveillance of Barrett’s esophagus: risk stratification and cancer risk. Gastrointest Endosc 49:S29–S34,1999

    Google Scholar 

  • Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MVJr: Methylene blue selectively stains intestinal metaplasia in Barrett’s esophagus. Gastrointest Endosc 44:1–7, 1996

    Google Scholar 

  • Canto M, Setrakian S, Chak A, Sivak MV Jr: Methylene blue-directed biopsy for improved detection of intestinal metaplasia and dysplasia in Barrett’s esophagus: A controlled sequential trial. Gastrointest Endosc 43:A165, 1996

    Google Scholar 

  • Canto MIF, Setrakian S, Willis J, Chak A, Petras R, Powe NR, Sivak MVJr: Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gastrointest Endosc 51:560–568, 2000

    Google Scholar 

  • Kiesslich R, Hahn M, Herrmann G, Jung M: Screening for specialized columnar epithelium with methylene blue: Chromoendoscopy in patients with Barrett’s esophagus and a normal control group.

  • Horwhat JD, Ramos F, Colina R, Maydonovitch CL, Wong RKH: Does dark staining or non-staining predict the presence of dysplasia in patients with Barrett’s esophagus undergoing methylene blue directed biopsies? Am J Gastroenterol 94: A80, 1999 (abstract)

    Google Scholar 

  • Gossner L, Pech O, May A, Stolte M, Ell C: Methylene blue staining for the detection of dysplasia or mucosal cancer in Barrett’s esophagus- a prospective trial. Gastroenterology 116:A414, 1999 (abstract)

    Google Scholar 

  • Gangarosa LM, Halter S, Mertz H: Methylene blue staining and endoscopic ultrasound evaluation of Barrett’s esophagus with low-grade dysplasia. Dig Dis Sci 45:225–229, 2000

    Google Scholar 

  • Mukunda BR, Mayfield-Stokes S, Cecil B, Forouzandeh B, Davis A, Wilson MA, Wo JM: Results of methylene blue-directed biopsy is similar to conventional biopsy for the diagnosis of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gastrointest Endosc 49:AB54, 1999 (abstract)

    Google Scholar 

  • Jobson B, Goenka P, Manalo G, Thomas E: Methylene blue staining for intestinal metaplasia in Barrett’s esophagus–is it as good as we think? Gastrointest Endosc 49:AB52, 1999 (abstract)

    Google Scholar 

  • Sueok N, Nishigaki H, Hiratsuka T, Tanaka S, Tatsuguchi A, Satoh J, Tsukuki T, Sakamoto C: Combined magnification video-endoscopy with methylene blue staining for the assessment of intestinal metaplasia in patients with Barrett’s esophagus. Gastrointest Endosc 49:AB54, 1999 (abstract)

    Google Scholar 

  • Canto MI: Vital staining and Barrett’s esophagus. Gastrointest Endosc 49:S12–S16, 1999

    Google Scholar 

  • Blot WJ, Devesa SS, Fraumeni JF: Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 270:320, 1993

    Google Scholar 

  • Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR: Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterol 104:510–513, 1993

    Google Scholar 

  • Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK: Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116:277–285, 1999

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marten B. Duncan DO.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duncan, M.B., Horwhat, J.D., Maydonovitch, C.L. et al. Use of Methylene Blue for Detection of Specialized Intestinal Metaplasia in GERD Patients Presenting for Screening Upper Endoscopy. Dig Dis Sci 50, 389–393 (2005). https://doi.org/10.1007/s10620-005-1616-y

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-1616-y

KEY WORDS

Navigation